Upstream Bio UPB
NASDAQ UPB
$5.04 -0.23 (-4.36%)
At close: Oct 1, 2026 · 4:00 PM EDT

Upstream Bio (UPB) Return on Equity [ROE] (2024 - 2026)

Updated

Upstream Bio (UPB) recorded Return on Equity [ROE] of -54.44% in Q2 2026, down 30.00 percentage points from -24.44% a year earlier and down 5.76 percentage points from the prior quarter.

Analysis

Upstream Bio (UPB) Return on Equity [ROE] (2024 - 2026) Analysis & Trends

For FY2025, Upstream Bio reported Return on Equity [ROE] of -35.43%, up 2.43 percentage points from FY2024.

  • Across earlier years, Return on Equity [ROE] came in at -37.86% in FY2024.
  • Per Business Quant, the preceding three quarters came in at -48.69% (Q1 2026), -39.93% (Q4 2025) and -31.03% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Upstream Bio 288.64 Mn 288.64 Mn -3.29 Mn -54.44%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -54.44%
Mar 31, 2026 -48.69%
Dec 31, 2025 -39.93%
Sep 30, 2025 -31.03%
Jun 30, 2025 -24.44%
Mar 31, 2025 -17.29%
Dec 31, 2024 -42.41%
API Access

Upstream Bio Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=UPB&period=max&api_key=YOUR_API_KEY